Human Milk Oligosaccharides (HMO) Milk Powder Market - Forecasts from 2025 to 2030
Description
The Human Milk Oligosaccharides (HMO) Milk Powder Market is set to witness robust growth at a CAGR of 11.16% during the forecast period to be worth US$ 5.409 billion in 2030 from US$ 3.187 billion in 2025.
The Human Milk Oligosaccharides (HMO) Milk Powder Market is experiencing robust demand due to the growing approval for the HMO milk powder from regulatory authorities. In August 2024, DSM-Firmenich announced the successful approval of its human milk oligosaccharide, 3-fucosyllactose (3-FL) and lacto-N-fucopentaose I/2'-fucosyllactose (LNFP-I/2'-FL) mixture. This approval is for the novel food ingredients in the United Kingdom and European Union. This is a significant development, opening up new possibilities for further product innovation and development. Additionally, the increased awareness about HMOs, such as improved gut health and immune support, is fueling market growth.
Market Trends:
HMO Approval in China for Infant Formula: Human milk oligosaccharides (HMOs), a key component of breast milk after lactose and lipids, were approved for use in various infant formula types in China in October 2023. This regulatory change has accelerated market growth, with companies like Novonesis, a leader in HMO development for the U.S. and Europe, now expanding into China. Other notable players include International Flavours and Fragrance (IFF), DSM-Firmenich, and local producer Mengniu.
North America: The HMO market is driven by major U.S.-based companies leading innovation in products such as infant formula, dietary supplements, functional foods, and beverages.
Asia-Pacific: Rapid urbanization and growing incomes in countries like China, India, and Southeast Asia are driving market expansion. Increased awareness of HMO milk powder benefits, coupled with rising disposable incomes, is fueling demand for premium alternatives to traditional food supplements.
Some of the major players covered in this report include BASF SE , Abbott Laboratories, Chr. Hansen Holding A/S, DuPont de Nemours, Inc., DSM-Firmenich, Royal FrieslandCampina N.V., ZuChem, Inc., Inbiose NV, among others.
Key Benefits of this Report:
Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.
What do businesses use our reports for?
Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence
Report Coverage:
Historical data from 2022 to 2024 & forecast data from 2025 to 2030
Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
Competitive Positioning, Strategies, and Market Share Analysis
Revenue Growth and Forecast Assessment of segments and regions including countries
Company Profiling (Strategies, Products, Financial Information, and Key Developments among others)
Human Milk Oligosaccharides (HMO) Milk Powder Market Segmentation:
By Type
2'-Fucosyllactose (2'FL)
3'-Fucosyllactose (3'FL)
3'-Sialyllactose (3'SL)
6'-Sialyllactose (6'SL)
Lacto-N-tetraose (LNT)
Lacto-N-neotetraose (LNnT)
Difucosyllactose (DFL)
By Application
Infant Formula
Dietary Supplements
Functional Foods and Beverages
Cosmetics
By Distribution Channel
Online Retailers
Supermarkets/hypermarkets
Specialty Stores
Convenience Stores
By Region
North America
Europe
Asia Pacific
South America
Middle East & Africa
The Human Milk Oligosaccharides (HMO) Milk Powder Market is experiencing robust demand due to the growing approval for the HMO milk powder from regulatory authorities. In August 2024, DSM-Firmenich announced the successful approval of its human milk oligosaccharide, 3-fucosyllactose (3-FL) and lacto-N-fucopentaose I/2'-fucosyllactose (LNFP-I/2'-FL) mixture. This approval is for the novel food ingredients in the United Kingdom and European Union. This is a significant development, opening up new possibilities for further product innovation and development. Additionally, the increased awareness about HMOs, such as improved gut health and immune support, is fueling market growth.
Market Trends:
HMO Approval in China for Infant Formula: Human milk oligosaccharides (HMOs), a key component of breast milk after lactose and lipids, were approved for use in various infant formula types in China in October 2023. This regulatory change has accelerated market growth, with companies like Novonesis, a leader in HMO development for the U.S. and Europe, now expanding into China. Other notable players include International Flavours and Fragrance (IFF), DSM-Firmenich, and local producer Mengniu.
North America: The HMO market is driven by major U.S.-based companies leading innovation in products such as infant formula, dietary supplements, functional foods, and beverages.
Asia-Pacific: Rapid urbanization and growing incomes in countries like China, India, and Southeast Asia are driving market expansion. Increased awareness of HMO milk powder benefits, coupled with rising disposable incomes, is fueling demand for premium alternatives to traditional food supplements.
Some of the major players covered in this report include BASF SE , Abbott Laboratories, Chr. Hansen Holding A/S, DuPont de Nemours, Inc., DSM-Firmenich, Royal FrieslandCampina N.V., ZuChem, Inc., Inbiose NV, among others.
Key Benefits of this Report:
Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.
What do businesses use our reports for?
Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence
Report Coverage:
Historical data from 2022 to 2024 & forecast data from 2025 to 2030
Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
Competitive Positioning, Strategies, and Market Share Analysis
Revenue Growth and Forecast Assessment of segments and regions including countries
Company Profiling (Strategies, Products, Financial Information, and Key Developments among others)
Human Milk Oligosaccharides (HMO) Milk Powder Market Segmentation:
By Type
2'-Fucosyllactose (2'FL)
3'-Fucosyllactose (3'FL)
3'-Sialyllactose (3'SL)
6'-Sialyllactose (6'SL)
Lacto-N-tetraose (LNT)
Lacto-N-neotetraose (LNnT)
Difucosyllactose (DFL)
By Application
Infant Formula
Dietary Supplements
Functional Foods and Beverages
Cosmetics
By Distribution Channel
Online Retailers
Supermarkets/hypermarkets
Specialty Stores
Convenience Stores
By Region
North America
Europe
Asia Pacific
South America
Middle East & Africa
Table of Contents
144 Pages
- 1. EXECUTIVE SUMMARY
- 2. MARKET SNAPSHOT
- 2.1. Market Overview
- 2.2. Market Definition
- 2.3. Scope of the Study
- 2.4. Market Segmentation
- 3. BUSINESS LANDSCAPE
- 3.1. Market Drivers
- 3.2. Market Restraints
- 3.3. Market Opportunities
- 3.4. Porter’s Five Forces Analysis
- 3.5. Industry Value Chain Analysis
- 3.6. Policies and Regulations
- 3.7. Strategic Recommendations
- 4. TECHNOLOGICAL OUTLOOK
- 5. HUMAN MILK OLIGOSACCHARIDES (HMO) MILK POWDER MARKET BY TYPE
- 5.1. Introduction
- 5.2. 2'-Fucosyllactose (2'FL)
- 5.3. 3'-Fucosyllactose (3'FL)
- 5.4. 3'-Sialyllactose (3'SL)
- 5.5. 6'-Sialyllactose (6'SL)
- 5.6. Lacto-N-tetraose (LNT)
- 5.7. Lacto-N-neotetraose (LNnT)
- 5.8. Difucosyllactose (DFL)
- 6. HUMAN MILK OLIGOSACCHARIDES (HMO) MILK POWDER MARKET BY APPLICATION
- 6.1. Introduction
- 6.2. Infant Formula
- 6.3. Dietary Supplements
- 6.4. Functional Foods and Beverages
- 6.5. Cosmetics
- 7. HUMAN MILK OLIGOSACCHARIDES (HMO) MILK POWDER MARKET BY DISTRIBUTION CHANNEL
- 7.1. Introduction
- 7.2. Online Retailers
- 7.3. Supermarkets/hypermarkets
- 7.4. Specialty Stores
- 7.5. Convenience Stores
- 8. HUMAN MILK OLIGOSACCHARIDES (HMO) MILK POWDER MARKET BY GEOGRAPHY
- 8.1. Introduction
- 8.2. North America
- 8.2.1. USA
- 8.2.2. Canada
- 8.2.3. Mexico
- 8.3. South America
- 8.3.1. Brazil
- 8.3.2. Argentina
- 8.3.3. Others
- 8.4. Europe
- 8.4.1. United Kingdom
- 8.4.2. Germany
- 8.4.3. France
- 8.4.4. Spain
- 8.4.5. Others
- 8.5. Middle East and Africa
- 8.5.1. Saudi Arabia
- 8.5.2. UAE
- 8.5.3. Others
- 8.6. Asia Pacific
- 8.6.1. China
- 8.6.2. Japan
- 8.6.3. India
- 8.6.4. South Korea
- 8.6.5. Taiwan
- 8.6.6. Others
- 9. COMPETITIVE ENVIRONMENT AND ANALYSIS
- 9.1. Major Players and Strategy Analysis
- 9.2. Market Share Analysis
- 9.3. Mergers, Acquisitions, Agreements, and Collaborations
- 9.4. Competitive Dashboard
- 10. COMPANY PROFILES
- 10.1. BASF SE
- 10.2. Abbott Laboratories
- 10.3. Chr. Hansen Holding A/S
- 10.4. DuPont de Nemours, Inc.
- 10.5. DSM-Firmenich
- 10.6. Royal FrieslandCampina N.V.
- 10.7. ZuChem, Inc.
- 10.8. Inbiose NV
- 10.9. Glycosyn LLC
- 10.10. Kirin Holdings Company, Limited (Kyowa Hakko Bio)
- 11. APPENDIX
- 11.1. Currency
- 11.2. Assumptions
- 11.3. Base and Forecast Years Timeline
- 11.4. Key benefits for the stakeholders
- 11.5. Research Methodology
- 11.6. Abbreviations
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.